News about Global Pharma

Innocan Pharma Files Divisional Patent in China for Liposome-based CBD Technology

Innocan Pharma has filed a divisional patent application in China for its liposome-based CBD delivery technology, marking a strategic move to expand its IP footprint in Asia’s rapidly growing pharmaceutical market.

Global Pharma | 08/04/2025 | By Manvi |  260

Stramsen Biotech Secures USD 25 Million Funding Commitment from GEM Global Yield LLC SCS

Stramsen Biotech Inc., a plant-based biopharmaceutical company, has secured USD 25 million in funding from GEM Global Yield LLC SCS to support its clinical development, global expansion, and the path toward a public listing.

Global Pharma | 08/04/2025 | By Manvi |  385

Ventris Medical Receives FDA 510(k) Clearance for Backpack Biologic Scaffold in Spinal Fusion Procedures

Ventris Medical announced that the United States Food and Drug Administration has granted 510(k) clearance for Backpack® (Porous Biologic Scaffold, K250556) for use in the Intervertebral Disc Space.

Global Pharma | 08/04/2025 | By Manvi |  152

4Moving Biotech Secures EUR 7.6M France 2030 Grant to Advance Osteoarthritis Drug

4MB's selection is a significant endorsement, granted through a rigorous, multi-stage evaluation process by leading scientific, clinical, and technological experts.

Global Pharma | 08/04/2025 | By Abha |  265

Dr JB Sharma Appointed as Head of Obstetrics & Gynaecology at Yashoda Medicity

Dr. J.B. Sharma is well-recognised for his work in Obstetrics and Gynaecology. He is in the top 2 percent of leading doctors in the world as per Stanford University.

Global Pharma | 08/04/2025 | By Abha |  789

ICU Medical Receives FDA Clearance for Plum Solo IV Pump, Expanding IV Performance Platform

ICU Medical Inc. has announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Solo™ precision IV pump, a single-channel complement to the dual-channel Plum Duo™.

Global Pharma | 07/04/2025 | By Manvi |  303

Sun Pharma Launches Novel Drug in India for Treatment of Erosive Esophagitis

Sun Pharmaceutical Industries Ltd. has launched FEXUCLUE (Fexuprazan 40 mg), a novel treatment for Erosive Esophagitis, in India under a licensing agreement with Korea’s Daewoong Pharmaceutical.

Global Pharma | 07/04/2025 | By Manvi |  540

Nelipak to Expands its Footprint in Asia-Pacific Region with Sterile Barrier Medical Packaging Products

The Nelipak® medical packaging product lineup includes a comprehensive range of custom designed sterile-barrier packaging solutions.

Global Pharma | 07/04/2025 | By Aishwarya |  341

Amneal Launches BORUZU for Multiple Myeloma and Mantle Cell Lymphoma

BORUZU™ (bortezomib injection), a proteasome inhibitor, is used for the treatment of multiple myeloma and mantle cell lymphoma.

Global Pharma | 07/04/2025 | By Aishwarya |  300

Centrient Pharmaceuticals Join Hands with Computer Shiksha to Transform Education in Punjab

By addressing the lack of digital education resources in these schools, the partnership between Centrient Pharmaceuticals and Computer Shiksha is paving the way for a more inclusive and digitally empowered society.

Global Pharma | 07/04/2025 | By Aishwarya |  200